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Abstract
Background: Extracellular superoxide dismutase (ECSOD) protects nitric oxide (NO)
bioavailability by decreasing superoxide levels and preventing peroxynitrite generation,
which is important in maintaining renal blood flow and in preventing acute kidney
injury. However, the profile of ECSOD expression after sepsis is not fully understood.
Therefore, we intended to evaluate the content and gene expression of superoxide
dismutase (SOD) isoforms in the renal artery and their relation to renal blood flow.
Methods: Sepsis was induced in Wistar rats by caecal ligation and perforation. Several
times after sepsis induction, renal blood flow (12, 24 and 48 h); the renal arterial
content of SOD isoforms, nitrotyrosine, endothelial and inducible nitric oxide synthase
(e-NOS and i-NOS), and phosphorylated vasodilator-stimulated phosphoprotein (pVASP);
and SOD activity (3, 6 and 12 h) were measured. The influence of a SOD inhibitor was
also evaluated.
Results: An increase in ECSOD content was associated with decreased 3-nitrotyrosine
levels. These events were associated with an increase in pVASP content and maintenance
of renal blood flow. Moreover, previous treatment with a SOD inhibitor increased
nitrotyrosine content and reduced renal blood flow.
Conclusions: ECSOD appears to have a major role in decreasing peroxynitrite
formation in the renal artery during the early stages of sepsis development, and
its application can be important in renal blood flow control and maintenance
during septic insult.
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Background
Sepsis is a complex syndrome characterized by an imbalance between pro-
inflammatory and anti-inflammatory responses to a pathogen [1, 2]. During its devel-
opment, a large amount of reactive oxygen species (ROS) and nitric oxide (NO) are
produced [3, 4]. In this context, superoxide radicals can react with NO to produce per-
oxynitrite [5, 6]. Peroxynitrite is a powerful oxidizing agent that is more cytotoxic than
NO and is implicated in endothelial dysfunction [7].
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The control of peroxynitrite levels and the bioavailability of NO depend, at least in
part, on SOD activity [5, 6]. Superoxide dismutases (SODs) are metalloenzymes that
catalyse the dismutation of the superoxide radical to hydrogen peroxide and oxygen.
Mammals have three distinct isoforms of SOD; copper/zinc-SOD (Cu/ZnSOD, SOD1),
manganese-SOD (MnSOD, SOD2) and extracellular (ECSOD, SOD3). ECSOD is pre-
dominantly localized in the extracellular matrix and the extracellular fluids depending
on the presence of a carboxy-terminal heparin-binding domain [5, 6]. ECSOD is se-
creted by various cells and binds to glycosaminoglycans in the vascular extracellular
matrix [8–10], maintaining NO bioavailability [11, 12]. Since the production of peroxy-
nitrite is associated with decreased renal blood flow and acute kidney injury [13, 14],
ECSOD could play a major protective role in this context, but little is known about its
modulation during sepsis.
Recently, we have demonstrated the role of ECSOD in lung injury after sepsis develop-
ment [15]. In a second set of experiments, we hypothesized that sepsis induces a decrease
in ECSOD levels in the renal artery and that this effect is associated with nitrosative stress
that decreases global renal blood flow and promotes acute kidney injury.
Methods
Animals
Male Wistar rats (350–400 g) were obtained from our own breeding colony. They were
caged in groups of five with free access to food and water and were maintained on a
12-h light–dark cycle (6:00–18:00 h) in a temperature-controlled colony room (22 ± 1 °C).
These conditions were maintained constantly throughout the experiments. The research
protocol was approved by the Ethical Committee for Animal Experimentation of Universi-
dade do Extremo Sul Catarinense under protocol number 21/2011, and the procedures
are in accordance with the National Institutes of Health guidelines for animal care.
Caecal ligation and perforation (CLP) surgery
The animals were subjected to CLP as previously described [15]. Briefly, rats were
anaesthetized with ketamine and, under aseptic conditions, a 3-cm midline laparotomy
was performed to allow for exposure of the caecum with the adjoining intestine. The
caecum was tightly ligated with a 3.0-silk suture at its base, below the ileocaecal valve,
and was perforated once with a 14-gauge needle. The caecum was then gently squeezed
to extrude a small amount of faeces, returned to the peritoneal cavity, and the laparot-
omy was closed with 4.0-silk sutures. Animals were resuscitated with normal saline
(50 mL/kg subcutaneous) immediately, 12 and 24 h after CLP, and were given antibi-
otics (ceftriaxone at 30 mg/kg and clindamycin 25 mg/kg) every 6 h and SC for the
entire duration of the experiments. In a set of experiments, a non-specific SOD inhibi-
tor, diethyldithiocarbamic acid diethylammonium (DETC, i.v. 7.5 mg/kg) [16, 17], was
administered immediately after sepsis induction. All animals were returned to their
cages with free access to food and water. In the sham-operated group, the rats were
submitted to all surgical procedures, but the caecum was neither ligated nor perforated.
All animals were observed and developed signs of infection (piloerection, lethargy,
tachypnea or weight loss). The number of animals that survived is consistent with our
previous reports.
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Direct measurement of renal blood flow
In this set of experiments, the animals were anaesthetized with ketamine/xylazine (90/
15 mg/kg, i.m.) and a transverse abdominal incision was performed to assess the pos-
terior right subhepatic space, allowing for the visualization of the right kidney. A laser
probe (model VP1) connected to a laser Doppler blood flow monitor (moorVMS-
LDF2, Moor Instruments, England) was carefully placed directly onto the kidney, allow-
ing for the measurement of renal blood flow (in arbitrary units). The probe was kept in
this position, and the surgical incision was covered with gauze sponges soaked in sterile
phosphate-buffered saline to protect the kidney from drying out. The laser probe
remained tightly fixed on the kidney surface, and very stable and constant trace record-
ings of renal blood flow were obtained. During the experiments, the animals were
maintained on a warming pad and allowed to breathe spontaneously. An interval of
20 min was observed before the measurement of basal values and renal blood flow was
measured for an additional 15 min [18].
Renal artery extraction and sample preparation
The animals were anaesthetized with ketamine and killed by decapitation at different
times after surgery. The renal arteries were dissected out under ×4 magnification on ice
and stored at −80 °C for posterior analyses.
Total SOD activity
SOD activity was measured by the inhibition of adrenaline auto-oxidation followed
spectrophotometrically as previously described [19].
Immunoblotting
Samples were lysed in Laemmli buffer (62.5 mM Tris-HCl, pH 6.8, 1% (w/v) SDS, 10% (v/v)
glycerol), and equal amounts of protein were fractionated by SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and electroblotted onto nitrocellulose membranes. Protein loading
and electroblotting efficiency were verified through Ponceau S staining, and the membrane
was blocked in Tween–Tris-buffered saline (TTBS: 100 mM Tris-HCl, pH 7.5, containing
0.9% NaCl and 0.1% Tween-20) containing 5% albumin. Membranes were incubated over-
night at 4 °C with rabbit polyclonal antibodies against SOD1 (1:400), SOD2 (dilution range,
1:400), SOD3 (dilution range, 1:750), iNOS (1:750), eNOS (1:750), pVASP (1:600) or β-actin
(1:2000) and then washed with TTBS. Anti-rabbit immunoglobulin G (IgG) peroxidase-
linked secondary antibody was incubated with the membranes for 1 additional hour
(1:10000 dilution range). The membranes were washed again, and the immunoreactivity
was detected by enhanced chemiluminescence using an ECL Plus kit. Densitometric ana-
lysis of the films was performed with ImageQuant software. Blots were developed to be lin-
ear in the range used for densitometry. All results were expressed as relative ratios between
SOD1, SOD2, SOD3, iNOS, eNOS and pVASP immunocontent and the β-actin internal
control immunocontent.
Analysis of gene expression by semi-quantitative RT-PCR
All transcriptional analyses were performed in samples that were different between
groups in the immunocontent in the blotting analysis with the goal of evaluating the
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contribution of each gene to the immunocontent of each enzyme. Total RNA was iso-
lated from rat renal arteries using TRIzol® reagent (Invitrogen, Carlsbad, CA, USA) in
accordance with manufacturer instructions. The purity of the RNA was spectrophoto-
metrically quantified by calculating the ratio between absorbance values at 260 and
280 nm, and its integrity was confirmed by electrophoresis through a 1.0% agarose gel.
Afterwards, cDNA species were synthesized using ImProm-II™ Reverse Transcription
System (Promega®) following the supplier's instructions. The cDNA products (1 μL)
were used as a template for each PCR amplification. PCR parameters were first opti-
mized, and then reactions were performed allowing for product detection within the
linear phase of mRNA transcript amplification for each primer pair. PCR for the β-actin
gene was performed in a total volume of 20 μL using 0.1 μM of each primer, 0.2 μM
dNTP, 1.6 mM MgCl2 and 0.2 U Taq platinum DNA polymerase (Invitrogen). In the PCR
for SOD1, SOD2 and SOD3, the reaction was performed in a total volume of 25 μL using
0.2 μM of each primer, 0.2 μM dNTP, 1.6 mM MgCl2 and 0.25 U Taq platinum DNA poly-
merase (Invitrogen). Conditions for sod 1, sod 2 and sod 3 PCR were as follows: an initial
1-min denaturation step at 94 °C; 1 min at 94 °C, a 1-min annealing step at 60 °C, and a 1-
min extension step at 72 °C for 30 cycles; and a final 10 min extension at 72 °C. Conditions
for β-actin PCR were as follows: an initial 1-min denaturation step at 94 °C; 1 min at 94 °C,
a 1-min annealing step at 54 °C, and a 1-min extension step at 72 °C for 35 cycles; and a
final 10-min extension at 72 °C. For each PCR set, a negative control was included. PCR
products were analysed on a 1% agarose gel containing GelRed® and visualized with ultra-
violet light. The Low DNA Mass Ladder (Invitrogen) was used as a molecular marker, and
samples were normalized by employing β-actin as a constitutive gene. The band intensities
were measured by optical densitometry analysis, and the enzyme/β-actin mRNA ratios
were established for each treatment using the freeware Image J 1.37. Each experiment was
repeated at least four times using RNA isolated from independent extractions.
Enzyme-linked immunosorbent assay (ELISA) for 3-nitrotyrosine contents
An indirect ELISA assay was performed according to the manufacturer’s instructions.
Briefly, microtiter plates were coated for 24 h with the samples diluted 1:2 in PBS with
5% albumin. Plates were then washed four times with wash buffer (PBS with 0.05%
Tween-20), and the antibody was added to each plate for 2 h at room temperature.
After washing, a second incubation with anti-rabbit antibody peroxidase conjugated
(diluted 1:1000) for 1 h at room temperature was carried out. After the addition of sub-
strates (hydrogen peroxide and tetramethylbenzidine 1:1, v/v), the samples were read at
450 nm in a plate spectrophotometer.
Statistical analysis
Data are expressed as the mean ± S.E.M and compared by the independent t test or
ANOVA followed by the Tukey post hoc test depending on the sample characteristics.
Statistical significance was set at p < 0.05.
Results
In this model, renal blood flow was maintained at early stages after sepsis induction
(Fig. 1). Compared to sham animals, renal blood flow remained unchanged at least
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until 48 h after CLP (Fig. 1). Since SOD is a factor in renal blood flow control, we fur-
ther investigated the protein content and expression of SOD in the renal arteries. Cu/
ZnSOD protein content decreased at 6 h, but not at 3 or 12 h, after the induction of
sepsis (Fig. 2a–c), which was not secondary to the downregulation of its gene expres-
sion (Fig. 2d). MnSOD content decreased from 6 to 12 h (Fig. 3a–c), but there was no
downregulation of its gene expression (Fig. 3d, e). In contrast, ECSOD increased at 6
and 12 h after surgery (Fig. 4a–c), which could be partially secondary to an increase in
































Fig. 1 Renal blood flow after sepsis induction. Sepsis was induced, and renal blood flow was measured at
12, 24 and 48 h. The dotted line represents sham renal blood flow. The values are presented as the mean ±
S.E.M., n = 6 in each group
Fig. 2 Superoxide dismutase 1 (SOD1) immunocontent and gene expression after sepsis induction by CLP.
Three times, 3 h (a), 6 h (b) and 12 h (c), after sepsis, the renal arteries were isolated, and the content of
SOD1 was quantified by immunoblot. Representative western blots show samples from shams in the first
bands and samples from sepsis in the last bands, represented in equal number. The densitometric analysis
quantification is depicted in bar graphs. Gene expression of SOD1 was measured by RT-PCR, with b-actin as
control, 6 h (d) after the induction of sepsis. The results are expressed as optical densitometry for the mean
± S.E.M. (n = 6 animals each group). *p < 0.05 compared to the sham group
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increased in septic animals when compared to sham animals at 6 and 12 h after sepsis
(2.3 ± 0.9 vs 30.1 ± 9, p < 0.01; 2.6 ± 1.1 vs 34.1 ± 12, p < 0.01, respectively).
We further measured the levels of nitrotyrosine, which decreased at 6 and 12 h after
sepsis (Fig. 5a–c). However, the immunocontent of iNOS was decreased only 6 h after
sepsis (Fig. 5d–f ), and there were no differences in the content of eNOS between the
groups and time (data not shown). To further evaluate the mechanisms involved in the
preservation of renal blood flow, we analysed the content of pVASP, which increased at
6 and 12 h after sepsis induction (Fig. 6).
To establish that the early increase in SOD content and activity was associated with
the control of renal blood flow, a SOD inhibitor was injected early after sepsis. SOD in-
hibition induced a decrease in renal blood flow at 48 h after sepsis induction, but not
at 12 and 24 h (Fig. 7a) and not in sham animals (data not shown). To determine
whether this treatment truly interfered with SOD activity, we demonstrated that it in-
duced a decrease in SOD activity (from 12 to 48 h after sepsis, Fig. 7b) but not in SOD
protein content (data not shown). Since the working hypothesis proposes that SOD ac-
tivity maintains NO bioavailability, we further measured the nitrotyrosine content that
was increased by SOD inhibition from 24 to 48 h (Fig. 7c).
Discussion
In a fluid-resuscitated model of sepsis, we have demonstrated that renal blood flow was
maintained, at least in part, secondary to the upregulation of ECSOD and SOD activity
in the renal arteries.
Fig. 3 Superoxide dismutase 2 (SOD2) immunocontent and gene expression after sepsis induction by CLP.
Three times, 3 h (a), 6 h (b) and 12 h (c), after sepsis, the renal arteries were isolated, and the content of
SOD2 was quantified by immunoblot. Representative western blots show samples from shams in the first
bands and samples from sepsis in the last bands, represented in equal number. The densitometric analysis
quantification is depicted in bar graphs. Gene expression of SOD2 was measured by RT-PCR, with b-actin as
control, 6 h (d) and 12 h (e) after the induction of sepsis in sham and sepsis groups. The results are expressed as
optical densitometry for the mean ± S.E.M. (n = 6 animals in each group). *p < 0.05 compared to the sham group





Fig. 4 Superoxide dismutase 3 (SOD3) immunocontent and gene expression after sepsis induction by CLP.
Three times, 3 h (a), 6 h (b) and 12 h (c), after sepsis, the renal arteries were isolated, and the content of
SOD3 was quantified by immunoblot. Representative western blots show samples from shams in the first
bands and samples from sepsis in the last bands, represented in equal number. The densitometric analysis
quantification is depicted in bar graphs. Gene expression of SOD3 was measured by RT-PCR, with b-actin as
control, 6 h (d) and 12 h (e) after the induction of sepsis in sham and sepsis groups. The results are expressed as
optical densitometry for the mean ± S.E.M. (n= 6 animals in each group). *p< 0.05 compared to the sham group
Fig. 5 Levels of 3-nitrotyrosine by ELISA and iNOS expression by blotting after sepsis induction by CLP. At
times 3 h (a), 6 h (b) and 12 h (c) after sepsis induction, the renal arteries were isolated, and the content of 3-
nitrotyrosine was quantified by ELISA and expressed in terms of nitrotyrosine concentration/absorbance. The
content of iNOS was measured by immunoblot 3 h (d), 6 h (e) and 12 h (f) after sepsis. Representative western
blots showed samples from shams in the first bands and samples from sepsis in the last bands, represented in
equal number. The densitometric analysis quantification is depicted in bar graphs. The results are expressed as
the mean ± S.E.M. in arbitrary units. (n = 6 animals in each group). *p < 0.05 compared to the sham group
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Fig. 6 Levels of phosphorylated vasodilator-stimulated phosphoprotein (pVASP) expression after sepsis induction.
Three times, 3 h, 6 h, and 12 h after sepsis, the renal arteries were isolated and the content of pVASP was
quantified by immunoblot. Representative western blots are positioned above the correspondent bar group, in
each sham and sepsis group, and densitometric analyses quantification is depicted in bar graphs. The results
are expressed as the mean ± S.E.M. in VASPSer239 phosphorylation (arbitrary units) (n = 6 animals in each group).
*p < 0.05 compared to the sham group
Fig. 7 The effect of administration of a superoxide dismutase inhibitor on renal blood flow, superoxide
dismutase activity and 3-nitrotyrosine content after sepsis induction. Immediately after sepsis induction, a
SOD inhibitor, diethyldithiocarbamic acid diethylammonium (DETC, i.v. 7.5 mg/kg), was administered. Several
times after sepsis induction (12, 24 and 48 h), renal blood flow was measured and (a) expressed as a percentage
difference compared to the sham group; superoxide dismutase activity (b) was expressed in SOD (U/mg
protein), and the 3-nitrotyrosine content (c) was expressed in nitrotyrosine content (arbitrary units). The dotted line
represents sham renal blood flow. The values are presented as the mean ± S.E.M., n= 6 in each group. *p < 0.05,
compared to CLP without SOD inhibitor at the same time point
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Acute kidney injury is a well-known, major complication in sepsis. In different
models of sepsis, renal hypoperfusion occurs and is associated with the generation of
peroxynitrite [20–22]. There are reports suggesting that peroxynitrite-induced PARP
activation is involved in renal hypoperfusion and in impaired endothelium-dependent
vasodilation [23]. In a model of endotoxaemia, ECSOD expression was decreased and
was consequently associated with decreased renal blood flow [12, 24]. In general, in
these models, the animals are not fully fluid resuscitated and antibiotic treatment is
missing. Here, in a more clinically relevant model of sepsis, we demonstrated that renal
blood flow could be maintained for at least 48 h, which is consistent with early goal-
directed therapy to preserve microcirculation both in animal models and in humans
[25–27]. In contrast, it was reported in a LPS model that, even when using fully
balanced fluids, compromises in microvascular and renal functions occurred [28]. This
unexpected result could be related to the regulation of NO production since peroxyni-
trite seems to be one of the most relevant mediators of sepsis-induced AKI [13, 20, 21].
SODs are the first defence system against superoxide anion radicals. Vascular smooth
muscle cells secrete large amounts of ECSOD, and it is thought that these cells are the
major source of the enzyme in the vascular wall [29]. Actually, ECSOD is widely
expressed in the cardiovascular system and in the kidney [30], and it is critical to
controlling 3-nitrotyrosine formation [31]. In addition, circulating microparticles from
septic patients are able to increase ECSOD expression in the rat heart [32], which is
consistent with our results. Therefore, despite the decreases in Mn and Cu/Zn SOD
content after sepsis, there is an increase in total SOD activity that is probably associ-
ated with the observed increase in ECSOD. These results suggest that ECSOD is of
major importance in maintaining kidney redox status early during sepsis. Actually,
post-ischaemic renal vasoconstriction is associated with an impairment of
endothelium-dependent NO-mediated vasodilation in renal vasculature [13, 33], but
ECSOD overexpression prevents endothelial dysfunction and preserves blood flow [34].
It has also been demonstrated that a SOD mimetic decreased superoxide formation in
the vascular compartment [35], which is consistent with our results. The maintenance
of renal blood flow is probably mediated by SOD quenching of superoxide, causing a
consequent decrease in peroxynitrite and improvement in vasorelaxation [36].
Therefore, if ECSOD is critical in regulating the redox state in the renal artery after
sepsis, it can be expected that it could decrease 3-nitrotyrosine formation, which was,
in fact, demonstrated in our model. Therefore, we propose that there is a decrease in
the availability of superoxide early after sepsis due to an increase in ECSOD content,
which in turn preserves NO levels to maintain renal blood flow. This is further sup-
ported by the fact that microparticles from septic patients did not change superoxide
anion and nitric oxide production in the rat kidney [32]. It is suggested that, even with-
out any detectable increase in NOS content, an increase in ECSOD would be sufficient
to maintain NO levels in conditions where superoxide production is increased, such as
in sepsis. NO plays a role in cyclic GMP-mediated smooth muscle relaxation leading to
the production of pVASP [37–39]. We demonstrated an increase in pVASP at 6 and
12 h after sepsis induction, which was temporally related to the increase in ECSOD
and the decrease in 3-nitrotyrosine, suggesting that NO signalling is preserved at these
early stages of sepsis. Similarly, Fisher 344 rats are able to increase ECSOD in response
to exercise as opposed to Sprague-Dawley rats, which indicates protection against acute
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kidney injury induced by ischaemia-reperfusion [40]. To ascertain that ECSOD plays a
critical role in the control of renal blood flow, we administered a SOD inhibitor to sep-
tic animals. Inhibition of SOD not only induced an increase in nitrotyrosine levels but
also resulted in decreased blood flow in later periods (48 h) of sepsis. One intriguing
fact is that the SOD inhibitor did not affect renal blood flow at 12 and 24 h after sepsis.
Actually, since the SOD inhibitor effectively inhibited SOD activity after 12 h, it was ex-
pected that nitrotyrosine levels and renal blood flow would also change, which occurs
at 48 h. This probably reflects a steady state between NO and superoxide that could be
affected by several other factors not assessed in our study. For example, it is well
known that arginase activity could decrease NO synthesis by competing with NOS for
arginine [41], and it has been demonstrated that arginase activity is modulated during
sepsis development [42]. In addition, the role of SOD in the development of acute
kidney injury was recently demonstrated in humans [43]. In septic shock patients,
higher erythrocyte SOD activity was independently associated with protection from
acute kidney injury [43]. However, the protective effects of ECSOD are also observed in
other different tissues during sepsis development [15, 44].
Some limitations must be highlighted. First, renal blood flow was measured at three
time points after sepsis, but renal blood flow may vary over time. Therefore, every hour
time point measures for quasi-continuous monitoring would be required. This proced-
ure would require a large number of animals (for each time point) or prolonged anaes-
thesia and mechanical ventilation, which could result in the generation of a different
bias that could interfere with the results. Although the timeline of such changes re-
mains to be further investigated by means of approaches that allow for the continuous
measurement of renal blood flow, our results provide insight into the pharmacological
use of an ECSOD mimetic to prevent kidney damage associated with sepsis. Second,
we did not directly measure NO levels; therefore, we cannot determine if ECSOD activ-
ity truly preserved NO levels in our model. This was only indirectly measured by nitro-
tyrosine levels, pVASP content and renal blood flow.
Conclusions
In conclusion, ECSOD has a relevant role in decreasing ONOO- formation in the renal
artery during early sepsis development, which can be an important step in the preserva-
tion of renal blood flow. These results provide insight into the pharmacological use of
an ECSOD mimetic to prevent kidney damage associated with sepsis.
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